Monday 6 July 2020
Home      All news      Contact us      Chinese
todayonline - 1 month ago

Sanofi to run consultations over restart of hydroxychloroquine trials

PARIS - Sanofi said on Wednesday it would review available information and run consultations before deciding whether to enroll patients again for its COVID-19-related hydroxychloroquine trials. The French drugmaker said on May 29 it had stopped recruiting new COVID-19 subjects for two clinical trials on hydroxychloroquine until concerns about safety are cleared up following a decision by the World Health Organization to pause a large trial. The WHO said earlier in the day the trial would resume. We will review available information and run consultations in the coming days to reassess our position, a spokesman with Sanofi said. REUTERS


Latest News
Hashtags:   

Sanofi

 | 

consultations

 | 

restart

 | 

hydroxychloroquine

 | 

trials

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources